Anonymous
Guest
Anonymous
Guest
Trokendi XR is predicted by most analysts to be a bust just like Oxtellar XR because of the current health care market in which we operate and the backwards model operated by Victor Vaughn.
We only recorded 579 prescriptions in the first 2 months and only made the company $3.6 million dollars which doesn't even get close to paying our salaries. IT also means that wil the 80 or so reps we have that we averaged only 7 scripts a territory over those 2 months or 3-4 a month per territory. That is pitiful and we won't have jobs soon if this keeps up.
We only recorded 579 prescriptions in the first 2 months and only made the company $3.6 million dollars which doesn't even get close to paying our salaries. IT also means that wil the 80 or so reps we have that we averaged only 7 scripts a territory over those 2 months or 3-4 a month per territory. That is pitiful and we won't have jobs soon if this keeps up.